Biophytis S.A.
BPTSNASDAQHealthcare
$8.22
$-1.28(-13.47%)
Market Cap$2608625
P/E Ratio—
52W High$168.8
52W Low$8.05
Biophytis S.A. (BPTS) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
BPTS · earnings · updated Jun 9, 2026
Latest Earnings
Q3 FY2024Report Date: Sep 25, 2024EPS Actual
-$1.79
Revenue
—
Fiscal Period
Q3 FY2024
FY ends December
Report Date
Sep 25, 2024
After Market Close
BPTS reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
84
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$1.20
Rev. $3.50B
Days Away84
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$1.20
Rev. Est.$3.50B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q2 FY2025 | Apr 7, 2025 | — | — | — | — | — | — |
| — Q3 FY2024 | Sep 25, 2024 | — | -$1.79 | — | — | — | — |
| ▼ Q2 FY2024 | Apr 8, 2024 | -$0.30 | -$5.37 | -1690.3% | — | — | — |
| ▼ Q3 FY2023 | Jul 21, 2023 | -$0.47 | -$10.34 | -2124.4% | — | — | — |
| ▼ Q2 FY2023 | Apr 18, 2023 | -$1.12 | -$25.22 | -2160.2% | — | — | — |
| — Q4 FY2022 | Nov 1, 2022 | — | -$17.55 | — | — | — | — |
| — Q2 FY2022 | May 26, 2022 | — | -$32.27 | — | — | — | — |
| — Q3 FY2021 | Sep 17, 2021 | — | -$28.40 | — | — | — | — |
Q2 FY2025
Apr 7, 2025
EPS Actual
—
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2024
Sep 25, 2024
EPS Actual
-$1.79
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2024
Apr 8, 2024Miss
EPS Actual
-$5.37
EPS Est.
-$0.30
EPS Surpr.
-1690.3%
Revenue
—
Q3 FY2023
Jul 21, 2023Miss
EPS Actual
-$10.34
EPS Est.
-$0.47
EPS Surpr.
-2124.4%
Revenue
—
Q2 FY2023
Apr 18, 2023Miss
EPS Actual
-$25.22
EPS Est.
-$1.12
EPS Surpr.
-2160.2%
Revenue
—
Q4 FY2022
Nov 1, 2022
EPS Actual
-$17.55
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q2 FY2022
May 26, 2022
EPS Actual
-$32.27
EPS Est.
—
EPS Surpr.
—
Revenue
—
Q3 FY2021
Sep 17, 2021
EPS Actual
-$28.40
EPS Est.
—
EPS Surpr.
—
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2023 | $-0.27 | $-0.27 | $-0.27 | 1 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2023 | $0.0B | $0.0B | $0.0B | 0 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| — Q3 FY2024 | Sep 25, 2024 | — | $7.62 | — | — |
| ▼ Q2 FY2024 | Apr 8, 2024 | -1690.3% | $13.76 | $12.80 | -6.98% |
| ▼ Q3 FY2023 | Jul 21, 2023 | -2124.4% | $90.83 | $89.20 | -1.79% |
| ▼ Q2 FY2023 | Apr 18, 2023 | -2160.2% | $149.60 | $146.00 | -2.41% |
| — Q4 FY2022 | Nov 1, 2022 | — | $232.08 | $239.48 | +3.19% |
| — Q2 FY2022 | May 26, 2022 | — | $480.00 | $508.00 | +5.83% |
| — Q3 FY2021 | Sep 17, 2021 | — | $3,428.00 | $3,428.00 | +0.00% |
| — Q1 FY2021 | Feb 26, 2021 | — | $6,572.00 | $6,600.00 | +0.43% |
Q3 FY2024—
Report Date
Sep 25, 2024
EPS Beat/Miss
—
Price Before
$7.62
Price After
—
Q2 FY2024-6.98%
Report Date
Apr 8, 2024
EPS Beat/Miss
-1690.3%
Price Before
$13.76
Price After
$12.80
Q3 FY2023-1.79%
Report Date
Jul 21, 2023
EPS Beat/Miss
-2124.4%
Price Before
$90.83
Price After
$89.20
Q2 FY2023-2.41%
Report Date
Apr 18, 2023
EPS Beat/Miss
-2160.2%
Price Before
$149.60
Price After
$146.00
Q4 FY2022+3.19%
Report Date
Nov 1, 2022
EPS Beat/Miss
—
Price Before
$232.08
Price After
$239.48
Q2 FY2022+5.83%
Report Date
May 26, 2022
EPS Beat/Miss
—
Price Before
$480.00
Price After
$508.00
Q3 FY2021+0.00%
Report Date
Sep 17, 2021
EPS Beat/Miss
—
Price Before
$3,428.00
Price After
$3,428.00
Q1 FY2021+0.43%
Report Date
Feb 26, 2021
EPS Beat/Miss
—
Price Before
$6,572.00
Price After
$6,600.00
Avg Miss Reaction-3.73%
Beat Rate0 / 8 quarters
Largest Move-6.98% (Q2 FY2024)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: BPTS ends December
Biophytis S.A. (BPTS) most recently reported earnings on September 25, 2024 for Q3 FY2024, posting EPS of $-1.79 (in line with the analyst consensus of —). The next BPTS earnings date is expected around September 1, 2026.
Each quarter, investors track BPTS earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. BPTS revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
BPTS's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
BPTS earnings · 4 questionsBiophytis S.A.'s next earnings report is expected around September 1, 2026. BPTS typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; BPTS historically reports after market close (AMC).
BPTS earnings datewhen is BPTS earningsBPTS next earnings datewhen does BPTS report earningsBPTS earnings calendar
▸ Source: FMP · Biophytis S.A. SEC filings · US GAAP · Biophytis S.A. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 9, 2026